The Relationship Between NLR and PONV and ESPB
The Relationship Between the Preoperative Neutrophil-to-lymphocyte Ratio (NLR) and Postoperative Nausea and Vomiting (PONV) in Lumbar Spine Surgery Patients, as Well as the Impact of Erector Spinae Plane Block on NLR and PONV
1 other identifier
interventional
220
0 countries
N/A
Brief Summary
This study aims to investigate whether preoperative NLR (Neutrophil-to-Lymphocyte Ratio) serves as a biomarker for PONV (Postoperative Nausea and Vomiting). It also examines the impact of erector spinae plane block on NLR and PONV. Furthermore, the research explores the effect of erector spinae plane block on postoperative pain relief in spinal surgery and its influence on the usage of opioid medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Aug 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2023
CompletedFirst Posted
Study publicly available on registry
November 13, 2023
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
July 29, 2025
July 1, 2025
1 year
October 29, 2023
July 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Record nausea and vomiting within the PACU and during the first 24 hours and second 24 hours after surgery.
Patients with a nausea and vomiting score of 1 point or above (0 points = no nausea, 1 point = nausea, 2 points = dry heaving, 3 points = vomiting) are treated with ondansetron as an antiemetic.
Within the first 24 hours and the second 24 hours after surgery.
Record the need for antiemetic medication within the PACU and during the first 24 hours and the second 24 hours postoperatively.
Record the need for antiemetic medication within the PACU and during the first 24 hours and the second 24 hours postoperatively.
Within the first 24 hours and the second 24 hours after surgery.
Record the neutrophil count and lymphocyte count on the first day after surgery and calculate the neutrophil-to-lymphocyte ratio (NLR)
The neutrophil count and lymphocyte count and calculate the neutrophil-to-lymphocyte ratio (NLR).
Within the first 24 hours.
Secondary Outcomes (10)
Overall VAS (Visual Analog Scale) pain scores at 2 hours, 6 hours, 12 hours, 24 hours, and 48 hours postoperatively during rest and movement.
At 2 hours, 6 hours, 12 hours, 24 hours, and 48 hours after surgery
Record the time of the patient's initial self-administration of the pain pump during the first 24 hours and the second 24 hours after surgery.
Within the first 24 hours and the second 24 hours after surgery
Record the time of the initial press of the patient-controlled analgesia pump.
Within the first 24 hours and the second 24 hours after surgery
Record the satisfaction scores for pain management at 24 and 48 hours.
Within the first 24 hours and the second 24 hours after surgery
Record the postoperative awakening time.
Within 24 hours.
- +5 more secondary outcomes
Study Arms (2)
Erector Spinae Plane Block group(EA group + EB group)
EXPERIMENTALConventional anesthesia induction, followed by ultrasound-guided erector spinae plane (ESPB) block with 0.5% ropivacaine (20 ml) after anesthesia induction.
Control group(CA group + CB group)
SHAM COMPARATORConventional anesthesia induction, followed by ultrasound-guided injection of 0.9% saline (20 ml) into the erector spinae plane (ESPB) after anesthesia induction.
Interventions
The patient assumes a prone position, and the appropriate lumbar vertebral level is identified using ultrasound, based on the preoperative markings of the surgical incision site. After disinfection, the ultrasound probe is placed in the parasagittal direction, 3 centimeters lateral to the midline, to identify the corresponding lumbar transverse process and the overlying erector spinae and latissimus dorsi muscles. Using an in-plane technique, the needle is advanced, and when the needle tip contacts the bony transverse process and there is no blood or gas upon aspiration, 2-3 mL of isotonic saline solution is injected to confirm the correct needle position. Local anesthetic is then injected between the erector spinae muscle and the transverse process. The spread of the local anesthetic in the deep fascial plane within the erector spinae muscle can be visualized using ultrasound.
The patient is placed in a prone position, and the appropriate lumbar vertebral level is determined using ultrasound based on the preoperative markings of the surgical incision site. After disinfection, the ultrasound probe is positioned in the parasagittal direction, 3 centimeters lateral to the midline, to identify the corresponding lumbar transverse process, erector spinae, and latissimus dorsi muscles above it. Using an in-plane technique, the needle is advanced, and when the needle tip contacts the bony transverse process, and there is no blood or gas upon aspiration, 2-3 milliliters of isotonic saline solution are injected to confirm the correct needle position. Subsequently, 20 milliliters of 0.9% physiological saline is injected between the erector spinae muscle and the transverse process. The diffusion of the physiological saline in the deep fascial plane within the erector spinae muscle can be visualized using ultrasound.
Eligibility Criteria
You may qualify if:
- Patients undergoing elective posterior lumbar spine surgery in a prone position under general anesthesia.
- ASA classification grades I to II.
- Age between 18 and 80 years old.
- Signed the informed consent for this study.
You may not qualify if:
- Preoperative blood transfusion.
- Uncontrolled systemic diseases.
- Patients with known uncontrolled systemic inflammatory diseases (e.g., rheumatoid arthritis, lupus, or active infections).
- Gastrointestinal system disorders.
- History of antiemetic and anticholinergic drug use.
- History of adverse reactions related to surgery, deformity correction surgeries, defined as procedures involving instrumentation across three or more levels or aimed at correcting scoliosis or kyphosis.
- Severe spinal deformities.
- Infection at the puncture site.
- Coagulation disorders.
- Long-term use of sedatives and analgesic drugs before surgery.
- Patients with mental illness or communication barriers.
- Allergic to ropivacaine.
- Participants involved in other clinical studies within the past 3 months.
- History of previous lumbar surgeries.
- Subjective unwillingness to participate in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Wang JJ, Wang Y, Li XF, Chen SS, Wang Y, Sun PY, Yang HK, Shi P, Wu G. The impact of erector spinae plane block on neutrophil-to-lymphocyte ratio and postoperative nausea and vomiting in lumbar spine surgery patients: a protocol for a randomized controlled trial. Front Med (Lausanne). 2025 Aug 28;12:1630821. doi: 10.3389/fmed.2025.1630821. eCollection 2025.
PMID: 40950965DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
October 29, 2023
First Posted
November 13, 2023
Study Start
August 1, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
July 29, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share